Apitope Plans 2013 Financing to Advance Autoimmune Drugs
By Nuala Moran
Wednesday, November 28, 2012
LONDON Apitope Ltd. is busy drawing up the business plan for a double-digit financing round to take its next two projects through Phase I development after triggering a key clinical milestone in its lead multiple sclerosis program.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.